Login  

 

The article you requested is

Performance Improvement CME: Managing Schizophrenia

J Clin Psychiatry 2011;72(10):e31
10.4088/JCP.9101pi7c

Schizophrenia is a highly disabling disorder characterized by positive and negative symptoms and poor functioning in almost every area of life. Multiple antipsychotics have demonstrated varying levels of efficacy in reducing symptoms in schizophrenia, but adverse effects are common, adherence to medication is low, and relapse rates are high. Psychosocial interventions used in conjunction with antipsychotic pharmacotherapy may help improve treatment outcomes. This Performance Improvement CME activity focuses on individualizing treatment for schizophrenia, assessing treatment adherence, minimizing medication-induced adverse events, and preventing relapse, for children, adolescents, and adults with schizophrenia.

This expired activity is not currently available online. Please send us an email to request it. Activities with user requests will receive priority as we make more expired activities available.​